Oncology PracticeEULAR issues guidelines on managing rheumatic complications of cancer immunotherapiesJune 14, 2019Immuno-oncologyImmunotherapy
Oncology PracticeAdjuvant immunotherapy results ‘encouraging’ in early NSCLCJune 11, 2019Lung CancerImmunotherapyImmuno-oncology
Oncology PracticeCheckpoint inhibitor rechallenge is possible for select patientsJune 6, 2019Immuno-oncologyImmunotherapyLung Cancer
Hematology NewsLow intensity bridging may be best path to CAR T in adult ALLJune 1, 2019ALLCellular TherapyLeukemia, Myelodysplasia, TransplantationImmuno-oncologyImmunotherapy
Oncology PracticeNovel anti-PD-1 antibody can be given subcutaneouslyMay 31, 2019Immuno-oncologyImmunotherapyHead & Neck/Thyroid Cancers
Hospital Physician: Hematology/OncologyAdvanced Melanoma: Treatment After Progression on First-line Therapy May 23, 2019MelanomaGI OncologyImmunotherapy
Hospital Physician: Hematology/OncologyAdvanced Melanoma: First-line TherapyMay 17, 2019MelanomaImmunotherapy
Hematology NewsICYMI: NIH renames, streamlines gene therapy committeeApril 26, 2019Cellular TherapyBusiness of MedicineAnemiaImmuno-oncologyImmunotherapyGene Therapy
Hematology NewsMonitoring, early intervention key to CAR T safetyApril 24, 2019Cellular TherapyAggressive LymphomasImmunotherapyB Cell LymphomaTransplantationImmuno-oncologyLymphoma & Plasma Cell Disorders
Hematology NewsFactors emerge for mitigating CD19 CAR T toxicityApril 22, 2019Cellular TherapyALLImmuno-oncologyImmunotherapy
Hematology TimesCreating CAR T-cell therapies for T-cell malignanciesApril 16, 2019ALLT Cell LymphomasLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationImmunotherapyCellular TherapyImmuno-oncology
Oncology PracticeHigher dose of checkpoint inhibitor every 4 weeks feasible in NSCLCMarch 7, 2019Lung CancerImmuno-oncologyImmunotherapy
Oncology PracticeBarriers to CAR T use in the spotlight at first European meetingFebruary 28, 2019Immuno-oncologyImmunotherapyB Cell LymphomaAggressive LymphomasCellular TherapyBusiness of MedicineGene Therapy
Oncology PracticeCMS proposes coverage of CAR T-cell therapy in trialsFebruary 15, 2019Practice ManagementBusiness of MedicineTransplantationImmuno-oncologyImmunotherapyGene Therapy
Oncology PracticeImmunotherapy’s cardiac effects require early monitoring, managementFebruary 5, 2019Immuno-oncologyImmunotherapyThrombosisPatient & Survivor CareMelanomaLeukemia, Myelodysplasia, TransplantationALL
